Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
Come and meet us at the following events:
14th European ISSX Meeting, 26th-29th June, Guerzenich, Cologne, Germany
254th ACS National Meeting & Exposition, 20th-24th August, Washington, DC
International Isotope Society Central European Division Workshop, 7th-8th September, Bad Soden, Germany
Download a copy of our brochure on drug metabolites and C-H activated derivatives
Our new brochure on drug metabolites and C-H activated derivatives is now available. Inside we feature interesting case studies and client projects, including the following topics:
- Phase l CYP and non-CYP metabolites
- Phase ll conjugated metabolites
- Isotopically labelled metabolites
- Lead diversification and late stage functionalization
- Polar / C-H activated derivatives
Download a copy of our latest newsletter
In our latest newsletter we present a project that helped our client to access structurally-unknown metabolites for MIST compliance. Hypha’s microbial biotransformation solution enabled producing sufficient amounts of the hydroxylated target metabolite for structural elucidations and further DMPK studies.